Is my portfolio
One Report to Answer all your Questions!
Sun Pharmaceutical Industries Ltd.
BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1645.55
11.15 (0.68%) Sun Pharmaceutical Industries informs about change in directorate
Date: 21-05-2021Sun Pharmaceutical Industries has informed that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, by way of circular resolutions passed on May 20, 2021, have approved the appointment of Pawan Goenka (DIN: 00254502), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021, to hold office upto the ensuing 29th Annual General Meeting of the Company; approved the appointment of Rama Bijapurkar (DIN: 00001835), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021 to hold office upto the ensuing 29th Annual General Meeting of the Company. The Company hereby confirmed that Pawan Goenka and Rama Bijapurkar are not related to any Director of the Company and are also not related to each other. It also confirmed that they both are not debarred from holding the office of Director by virtue of any order issued by the Securities and Exchange Board of India (SEBI) or any such other authority in accordance with the circular dated June 20, 2018, issued by the Stock Exchanges
The above information is a part of company’s filings submitted to BSE.